Cardiovascular Devices
Latin America
Updated
Reviewed by Vidhi Upadhyay
Latin America Ophthalmic Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Disease, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.07 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.22 Bn | — | — |
| 2025 (base) | $2.38 Bn | +$159.7 Mn | — |
| 2026 (forecast) | $2.55 Bn | +$171.2 Mn | +7.2% |
| 2027 (forecast) | $2.73 Bn | +$183.5 Mn | +14.9% |
| 2028 (forecast) | $2.93 Bn | +$196.7 Mn | +23.2% |
| 2029 (forecast) | $3.14 Bn | +$210.9 Mn | +32.1% |
| 2030 (forecast) | $3.37 Bn | +$226.0 Mn | +41.6% |
| 2031 (forecast) | $3.61 Bn | +$242.3 Mn | +51.8% |
| 2032 (forecast) | $3.87 Bn | +$259.8 Mn | +62.7% |
| 2033 (forecast) | $4.15 Bn | +$278.5 Mn | +74.4% |
| 2034 (forecast) | $4.44 Bn | +$298.5 Mn | +87% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $2.38 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $4.44 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, disease and end user (see all) |
| Key players | Alcon, Johnson & Johnson, Bausch and Lomb, Carl Zeiss Meditec, The Cooper Companies Inc. and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Ophthalmic devices diagnose and treat eye disease and vision problems, from eye scanners to surgical lasers and lenses.
Key segments of the ophthalmic devices market include product (Surgical Devices, Diagnostic and Monitoring Devices and Vision Correction) and disease (Cataract, Glaucoma and Retinal Disorders).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the ophthalmic devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the ophthalmic devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the ophthalmic devices market.
The ophthalmic devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)[1], ARCSA (Ecuador)[2], COFEPRIS (Mexico)[3], ANMAT (Argentina)[4], INVIMA (Colombia)[5] and ISP (Chile)[6]. How care is paid for in some of these countries: the SUS (Brazil)[7]; public care and IESS (Ecuador)[8]; IMSS, ISSSTE and IMSS-Bienestar (Mexico)[9]; public care, obras sociales and prepaid plans (Argentina)[10]; social health insurance (EPS) (Colombia)[11]; and FONASA and ISAPREs (Chile)[12].
[1] ANVISA. Checked 14 Nov 2026.
[2] ARCSA. Checked 14 Nov 2026.
[3] COFEPRIS. Checked 14 Nov 2026.
[4] ANMAT. Checked 19 Nov 2026.
[5] INVIMA. Checked 19 Nov 2026.
[6] Institute of Public Health of Chile (ISP). Checked 19 Nov 2026.
[7] CONITEC. Checked 14 Nov 2026.
[8] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.
[9] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
[10] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.
[11] Ministry of Health and Social Protection. Checked 19 Nov 2026.
[12] FONASA. Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ophthalmic devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.
What doctors and scientists are doing in Ophthalmic Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Latin America
Latin America
Latin America
Latin America
Latin America
Latin America
Digital Health · Latin America
Digital Health · Latin America
Healthcare Services · Latin America
Healthcare Services · Latin America
Pharmaceuticals · Latin America
Healthcare Services · Latin America